Clover Biopharmaceuticals Statistics

Total Valuation

HKG:2197 has a market cap or net worth of HKD 330.75 million. The enterprise value is -16.57 million.

Market Cap	330.75M
Enterprise Value	-16.57M

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2197 has 1.30 billion shares outstanding. The number of shares has increased by 0.82% in one year.

Current Share Class	1.30B
Shares Outstanding	1.30B
Shares Change (YoY)	+0.82%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	20.32%
Owned by Institutions (%)	8.96%
Float	805.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.09
PB Ratio	-0.19
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.05

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-165.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-40.96%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	87.21%
Revenue Per Employee	136,281
Profits Per Employee	-3.20M
Employee Count	300
Asset Turnover	0.03
Inventory Turnover	2.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.08% in the last 52 weeks. The beta is 3.57, so HKG:2197's price volatility has been higher than the market average.

Beta (5Y)	3.57
52-Week Price Change	-31.08%
50-Day Moving Average	0.22
200-Day Moving Average	0.27
Relative Strength Index (RSI)	53.76
Average Volume (20 Days)	1,699,247

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2197 had revenue of HKD 40.88 million and -961.40 million in losses. Loss per share was -0.77.

Revenue	40.88M
Gross Profit	-716.13M
Operating Income	-1.02B
Pretax Income	-961.40M
Net Income	-961.40M
EBITDA	-985.89M
EBIT	-1.02B
Loss Per Share	-0.77

Full Income Statement

Balance Sheet

The company has 442.72 million in cash and 95.40 million in debt, giving a net cash position of 347.32 million or 0.27 per share.

Cash & Cash Equivalents	442.72M
Total Debt	95.40M
Net Cash	347.32M
Net Cash Per Share	0.27
Equity (Book Value)	-1.74B
Book Value Per Share	-1.34
Working Capital	-1.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -307.00 million and capital expenditures -1.21 million, giving a free cash flow of -308.20 million.

Operating Cash Flow	-307.00M
Capital Expenditures	-1.21M
Free Cash Flow	-308.20M
FCF Per Share	-0.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,485.33%
Pretax Margin	-2,351.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2197 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.82%
Shareholder Yield	n/a
Earnings Yield	-290.67%
FCF Yield	-93.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2197 has an Altman Z-Score of -23.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.73
Piotroski F-Score	3